Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul><li>What you need to know: • IEHC announced that it has signed $3.6M in orders for mobile defibrillator applications.</li><li>This gives us increased confidence that IEHC’s hyperboloid connectors have strong applications in the healthcare industry.</li><li>• The other/medical segment represented only 3.8% of sales in FY26 or ~$1.1M, and as such, is growing off a small base.</li></ul>

What you need to know: • IEHC announced that it has signed $3.6M in orders for mobile defibrillator applications.This gives us increased confidence that IEHC’s hyperboloid connectors have strong applications in the healthcare industry.• The other/medical segment represented only 3.8% of sales in FY26 or ~$1.1M, and as such, is growing off a small base.

IEHC: $3.6M in Orders; Diversifying Sales via Medical Industry

IEH Corp

IEHC: $3.6M in Orders; Diversifying Sales via Medical Industry